Quarterly Results
No data
CBAY Earnings Forecast
1Y
3Y
5Y
Currency: USD
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price0
Earnings Forecast
Revenue
EPS
Currency:
No data
Actual
Estimate
Al Analysis
Earnings Surprise Analysis
Revenue
EPS
1Y
3Y
Al Analysis
Earnings Reaction
The chart below shows how CBAY performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CBAY sees a +0.00% change in stock price 10 days leading up to the earnings, and a +0.00% change 10 days following the report. On the earnings day itself, the stock moves by +0.00%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in , the stock changed % on the day following the earnings release and then changed by % over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
No data
People Also Watch
Frequently Asked Questions
What were the key highlights of CBAY's latest earnings report for undefined?
CBAY reported its earnings on , showcasing a revenue of undefined against an estimate of undefined, resulting in a NaN% surprise. The EPS was NaN, surpassing the expected NaN by NaN% . The stock experienced a NaN% price change on the earnings day and a NaN% change over the next five days, reflecting market reactions to the results.
How did CBAY's stock price react after the undefined earnings release?
Following CBAY's earnings announcement on , the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, CBAY's stock price tends to shift by an average of +0.00% in the 10 days leading up to earnings and +0.00% in the 10 days following, providing insight into potential market.
What are the revenue and EPS estimates for CBAY for undefined?
For , analysts estimate CBAY’s annual revenue to reach undefined, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by % and EPS estimates No Change by % over the past three months, indicating analyst expectation in the company’s performance.
How does CBAY's stock price correlate with earnings forecast revisions?
The correlation between CBAY's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for were No Change by %, while EPS estimates moved No Change by % . This trend suggests that price dips could present buying opportunities for investors.
What should investors expect from CBAY's next earnings report?
Based on historical trends, CBAY's stock price typically moves by +0.00% in the 10 days before its earnings and +0.00% in the 10 days after. For the upcoming earnings, analysts expect an EPS of undefined and revenue of undefined.
What is the sentiment in CymaBay Therapeutics Inc (CBAY) Q3 2023 Earnings Call Summary?
The earnings call reveals increased net loss and operating expenses, which is a negative indicator. While there are efforts towards commercialization and regulatory submissions, the lack of specific guidance and the exclusion of EU launch costs from the cash runway are concerning. The Q&A reveals uncertainties in regulatory timelines and costs, and while there is optimism about seladelpar's potential, the financial outlook and guidance are weak, likely leading to a negative stock reaction.